Mt. Sinai receives NIH grant for microscope that sees real-time cellular activity

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Institutes of Health has awarded a $1.2 million grant to the Mount Sinai Microscopy Core for a state-of-the-art microscope with resolution capabilities that can show structures as small as viruses. The instrument will be used by research teams throughout Mount Sinai Health System.

The grant will fund the purchase of a Leica TCS SP8 STED 3X, a super-resolution microscope, the first at Mount Sinai Health System. This new microscope will allow researchers to perform fluorescence nanoscopy and the ability to see tiny cellular processes that have previously been impossible to see.

The microscope will enable researchers to learn about several cellular processes, by, for example, observing a virus infecting the body, or seeing the molecular changes that occur when a tumor progresses to metastasis. The microscope’s super-resolution abilities will allow researchers to make gains in the study of viral infection, neurodegenerative disease progression, developmental brain disorders, metastasis, glaucoma, stress, and depression.

The microscope is set for installation in mid-December and will be accessible to all researchers in various areas of medicine throughout the health system.

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login